TickerFactsScreenerDevelopers

Cartesian Therapeutics, Inc. (RNAC) — Operating Income

Annual figures by fiscal year, from SEC filings.

2014: -$15.40M2015: -$25.30M2016: -$34.67M2017: -$63.78M2018: -$65.02M2019: -$52.45M2020: -$56.82M2021: -$4.60M2022: $14.54M2023: -$86.42M2024: -$43.90M2025: -$143.41M-$143.41M
2014Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$143.41M-226.7%
2024-$43.90M+49.2%
2023-$86.42M-694.4%
2022$14.54M+416.2%
2021-$4.60M+91.9%
2020-$56.82M-8.3%
2019-$52.45M+19.3%
2018-$65.02M-1.9%
2017-$63.78M-84.0%
2016-$34.67M-37.0%
2015-$25.30M-64.3%
2014-$15.40M—